Nothing Special   »   [go: up one dir, main page]

ES8802584A1 - Un metodo de comprobar la eficacia del proceso de purificacion de un producto preparado por la tecnica del adnr - Google Patents

Un metodo de comprobar la eficacia del proceso de purificacion de un producto preparado por la tecnica del adnr

Info

Publication number
ES8802584A1
ES8802584A1 ES552519A ES552519A ES8802584A1 ES 8802584 A1 ES8802584 A1 ES 8802584A1 ES 552519 A ES552519 A ES 552519A ES 552519 A ES552519 A ES 552519A ES 8802584 A1 ES8802584 A1 ES 8802584A1
Authority
ES
Spain
Prior art keywords
product
efficiency
purification
recombinant dna
product purity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552519A
Other languages
English (en)
Other versions
ES552519A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES8802584A1 publication Critical patent/ES8802584A1/es
Publication of ES552519A0 publication Critical patent/ES552519A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
    • B01D61/44—Ion-selective electrodialysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

METODO PARA COMPROBAR LA EFICACIA DEL PROCESO DE PURIFICACION DE UN PRODUCTO POR LA TECNICA DE ACIDO DESOXITTIBONUCLEICO RECOMBINANTE (ADNR) QUE COMPRENDE COMBINAR EL PRODUCTO, ANTES DE LA PURIFICACION, CON UNA CANTIDAD PREDETERMINADA DE CONTAMINANTE HIDROFOBO DEL HOSPEDANTE MARCADO RADIACTIVAMENTE O DE OTRO MODO Y PURIFICAR A CONTINUACION EL PRODUCTO CONTAMINADO POR CONTAMINANTE MARCADO DEL HOSPEDANTE, DETERMINANDOSE DESPUES LA CANTIDAD DE CONTAMINANTE MARCADO PRESENTE EN EL PRODUCTO PURIFICADO. DE APLICACION PARA EVITAR LA FORMACION DE ANTICUERPOS CUANDO EL PRODUCTO VA A ADMINISTRARSE DURANTE LARGO TIEMPO, P.EJ. EN ENFERMEDADES CRONICAS COMO LA DIABETES. I
ES552519A 1984-05-28 1986-02-28 Un metodo de comprobar la eficacia del proceso de purificacion de un producto preparado por la tecnica del adnr Expired ES8802584A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8402861A SE8402861L (sv) 1984-05-28 1984-05-28 Rening av biologiskt material

Publications (2)

Publication Number Publication Date
ES8802584A1 true ES8802584A1 (es) 1988-08-01
ES552519A0 ES552519A0 (es) 1988-08-01

Family

ID=20356050

Family Applications (3)

Application Number Title Priority Date Filing Date
ES543512A Expired ES8609474A1 (es) 1984-05-28 1985-05-27 Un metodo de purificar un producto (proteina-peptido) conta-minado, preparado por tecnica de adnr
ES552519A Expired ES8802584A1 (es) 1984-05-28 1986-02-28 Un metodo de comprobar la eficacia del proceso de purificacion de un producto preparado por la tecnica del adnr
ES552518A Expired ES8802583A1 (es) 1984-05-28 1986-02-28 Un metodo de comprobar la pureza de un producto (proteinanpeptido)producido por la tecnica de adnr.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES543512A Expired ES8609474A1 (es) 1984-05-28 1985-05-27 Un metodo de purificar un producto (proteina-peptido) conta-minado, preparado por tecnica de adnr

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES552518A Expired ES8802583A1 (es) 1984-05-28 1986-02-28 Un metodo de comprobar la pureza de un producto (proteinanpeptido)producido por la tecnica de adnr.

Country Status (20)

Country Link
US (1) US4746647A (es)
EP (1) EP0185700A1 (es)
JP (1) JPS61502378A (es)
KR (1) KR860700135A (es)
AU (1) AU4435885A (es)
BR (1) BR8506758A (es)
CS (1) CS257789B2 (es)
DD (1) DD241748A5 (es)
DK (1) DK39786A (es)
ES (3) ES8609474A1 (es)
FI (1) FI860316A0 (es)
HU (1) HUT39774A (es)
IL (1) IL75258A0 (es)
IN (1) IN162119B (es)
NO (1) NO860295L (es)
NZ (1) NZ212155A (es)
PL (1) PL253664A1 (es)
SE (1) SE8402861L (es)
WO (1) WO1985005631A1 (es)
ZA (1) ZA853918B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
DE3526096A1 (de) * 1985-07-22 1987-01-22 Basf Ag Verfahren zur reinigung von htnf
US4894439A (en) * 1986-05-22 1990-01-16 Cetus Corporation N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
US4798886A (en) * 1986-03-24 1989-01-17 Takeda Chemical Industries, Ltd. Mutual separation of proteins
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
DE3724442A1 (de) * 1987-07-23 1989-02-02 Europ Lab Molekularbiolog Verfahren und vorrichtung zur reinigung von m-13-phagen-dna
US5147779A (en) * 1988-06-01 1992-09-15 Miles Inc. Method for evaluating immunogenicity
AUPP521298A0 (en) * 1998-08-12 1998-09-03 Life Therapeutics Limited Purification of fibrinogen
AUPP790898A0 (en) 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
US20050224355A1 (en) * 1999-12-23 2005-10-13 Brendon Conlan Removal of biological contaminants
AUPP790698A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Separation of microorganisms
AUPP971399A0 (en) 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
US7077942B1 (en) * 1999-12-23 2006-07-18 Gradipore Limited Removal of biological contaminants
AUPQ691400A0 (en) 2000-04-14 2000-05-11 Life Therapeutics Limited Separation of micromolecules
JP2003531362A (ja) 2000-04-18 2003-10-21 グラディポア・リミテッド 試料の電気泳動性分離および処理
AUPQ697300A0 (en) 2000-04-18 2000-05-11 Life Therapeutics Limited Separation apparatus
US6923896B2 (en) * 2000-09-22 2005-08-02 The Texas A&M University System Electrophoresis apparatus and method
DE60142520D1 (de) * 2000-10-06 2010-08-19 Arturus Capital Ltd Multi-port-elektrophorese-trennvorrichtung und entsprechendes verfahren
AUPR222300A0 (en) * 2000-12-21 2001-01-25 Life Therapeutics Limited Electrophoresis device and method
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
GB201204756D0 (en) * 2012-03-19 2012-05-02 Lewi Paulus J Triazines with suitable spacers for treatment and/or prevention of HIV infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
SE7804098L (sv) * 1977-04-20 1978-10-21 R & Z Vermoegensverw Gmbh Peptidkomplex fran dna-haltiga organismer
US4322275A (en) * 1980-01-10 1982-03-30 Ionics Incorporated Fractionation of protein mixtures
US4276140A (en) * 1980-01-10 1981-06-30 Ionics Inc. Electrodialysis apparatus and process for fractionating protein mixtures
US4351710A (en) * 1980-01-10 1982-09-28 Ionics, Incorporated Fractionation of protein mixtures
US4426323A (en) * 1980-01-10 1984-01-17 Ionics, Incorporated Selected recovery of proteins from fermentation broths
US4321192A (en) * 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The ＨＢｓＡｇの精製方法

Also Published As

Publication number Publication date
ES8802583A1 (es) 1988-08-01
SE8402861L (sv) 1985-11-29
ES543512A0 (es) 1986-08-01
IL75258A0 (en) 1985-09-29
CS368485A2 (en) 1987-11-12
SE8402861D0 (sv) 1984-05-28
FI860316A (fi) 1986-01-22
ES552518A0 (es) 1988-08-01
AU4435885A (en) 1985-12-31
DD241748A5 (de) 1986-12-24
US4746647A (en) 1988-05-24
DK39786D0 (da) 1986-01-27
JPS61502378A (ja) 1986-10-23
ES8609474A1 (es) 1986-08-01
EP0185700A1 (en) 1986-07-02
PL253664A1 (en) 1986-02-11
NZ212155A (en) 1988-10-28
BR8506758A (pt) 1986-09-23
CS257789B2 (en) 1988-06-15
WO1985005631A1 (en) 1985-12-19
ES552519A0 (es) 1988-08-01
IN162119B (es) 1988-04-02
ZA853918B (en) 1986-01-29
NO860295L (no) 1986-01-28
KR860700135A (ko) 1986-03-31
DK39786A (da) 1986-01-27
HUT39774A (en) 1986-10-29
FI860316A0 (fi) 1986-01-22

Similar Documents

Publication Publication Date Title
ES8802584A1 (es) Un metodo de comprobar la eficacia del proceso de purificacion de un producto preparado por la tecnica del adnr
DE59409712D1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
NZ320802A (en) Purified mannanase from Bacillus amyloliquefaciens
AU1672388A (en) Expression of human proapolipoprotein a-i
EP0263518A3 (en) Purification of recombinant tumor necrosis factor
AU4015101A (en) Method for separating a basic amino acid from fermentation broth
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
DE69311337D1 (de) Verfahren zur Reinigung von Proteinen
ES8404514A1 (es) Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad
MX2024009755A (es) Metodos de purificacion de un producto.
DE3850774D1 (de) Rinder-interleukin-1-alpha.
DE68928889D1 (de) Enzymatisches Reinigungsverfahren
CA2088068A1 (en) Protein structure of the plant toxin gelonin
HUT72924A (en) Displacement chromatography process and purified hemoglobin product
EP0422217A4 (en) Human recombinant placental ribonuclease inhibitor and method of production
JPS5489011A (en) Preparation of interferon
ITRM920385A1 (it) Procedimento per la purificazione di proteine da sistemi cellulari.
CA2006665A1 (en) Process for purification of 1,2-bis (nicotinamido) propane
KR970009339B1 (en) Tpa from scolopendra subepinpes multilans and its purification method
AU2860384A (en) Cloning vector,method of constructing such,and method of concentrating and purifying product proteins produced by the cloning vector
TW368505B (en) A process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same